Haleon
Haleon sees sluggish Q1 growth on tepid flu season, China demand
British consumer healthcare giant Haleon said on Thursday (Feb 29) its first-quarter organic revenue growth would slow, citing a tepid cold and flu season and cooling China demand.
Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More
